Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Remedica Ltd, Acharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Frumeron 2.5 mg coated tablets.
| Pharmaceutical Form |
|---|
|
Coated tablets. Light pink, round, coated tablets. |
Each coated tablet contains indapamide 2.5 mg.
Excipients with known effect:
This product contains 38.961 mg lactose, 47.246 mg sucrose and 0.001 mg ponceau 4R E124.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Indapamide |
Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action. |
| List of Excipients |
|---|
|
Core: Lactose monohydrate Coating: Hypromellose |
PVC/Aluminium blisters. Pack sizes of 30 and 1000 coated tablets.
PP containers with PE closure. Pack size of 1000 coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Acharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
10375
Date of first authorisation: 03 February 1986
Date of latest renewal: 19 April 2013
| Drug | Countries | |
|---|---|---|
| FRUMERON | Cyprus, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
